贾跃亭表示，至此，FX首阶段八大州已攻破六个，提前完成了今年的拓展目标，同时也标志着FX的共 创生态线上直销模式成功拓展到了高端豪华民宿行业，这是FX在B2B2C体系继汽车租赁、FX Par、房 产经纪、MCN、汽车点对点分时共享之后的又一次跨界化反。 12月15日消息，法法创始人、合伙人、首席产品及用户生态官，LeEco乐视创始人贾跃亭发布周报，宣 布FX与佛罗里达州豪华民宿投资运营公司Golden Hill Investment LLC签署2000台FX Super One付费预订 单合同，已收到全部不可退定金，成功打入美国电动车消费大州之一的佛州。 ...

12月13日，重庆长安汽车（000625）股份有限公司发布《第九届董事会第四十九次会议决议公告》(公 告编号：2025-78)称，审议通过聘任赵非为公司总裁等议案，任期至第九届董事会任期届满。根据公 告，赵非目前持有公司A股23.86万股，相关任命即刻生效。 ...

其中提到，升级商品消费。加强大宗耐用消费品、数码产品等消费金融服务，挖掘商品消费升级潜能。 推动金融机构与平台、重点商户合作，加快推动个人消费贷款业务发展。适当减免汽车以旧换新过程中 提前结清贷款产生的违约金。完善消费品以旧换新服务平台，扩大金融机构参与范围。 近日，商务部办公厅、中国人民银行办公厅、金融监管总局办公厅发布《关于加强商务和金融协同，更 大力度提振消费的通知》。 ...

近日，商务部公布《关于申请二手车和改装车出口许可证有关事项的工作指引(企业版)》。其中对申请 改装车出口许可证要求，要提供改装说明，改装材料要件包括改装内容详细说明及相关照片，以及改装 前后车辆正前、左前、正侧、尾部对比照片等。 ...

尤峥因工作调整原因辞去赛力斯公司第五届董事会非执行董事职务。尤峥未持有赛力斯公司股份。 赛力斯公司董事会同意提名杨彦鼎为公司第五届董事会非执行董事候选人，任期自公司股东会审议通过 之日起至第五届董事会任期届满。 作者丨彭鑫 编辑丨安安 近日，赛力斯集团股份有限公司发布《关于非执行董事变更的公告》（公告编号2025-105）称，公司于 近日收到股东东风汽车集团有限公司《关于尤峥、杨彦鼎两人职务任免的函》，并收到尤峥向赛力斯提 交的书面辞职报告。 ...

Core Insights - The article highlights the rise of Zhejiang University entrepreneurs, particularly focusing on the innovative strides made by TreeLan Medical Group under the leadership of Zheng Jie, emphasizing a dual-driven strategy of healthcare and technology [1][3]. Company Overview - TreeLan Medical Group has evolved into a technology-driven healthcare organization that integrates health services, medical research, and education, establishing a comprehensive service model from treatment to health management [1][3]. - Zheng Jie, the founder and chairman, emphasizes a commitment to a long-term vision that transcends short-term gains, aiming to redefine healthcare services through technology [1][3]. Technological Integration - The company has developed a proprietary Hospital Information System (HIS) to digitize core medical processes, enhancing service quality and patient experience [3][4]. - TreeLan Medical has positioned itself to leverage AI technologies, with a focus on creating an AI future hospital that redefines the boundaries of medical services [1][5]. AI Applications - The introduction of AI health assistant Dr.Shu aims to streamline the patient journey from symptom consultation to appointment scheduling, enhancing the overall healthcare experience [6][8]. - The AI pathology assistant significantly reduces diagnosis time by automating the analysis of pathology slides, improving diagnostic accuracy and efficiency [7][9]. Future Vision - TreeLan Medical is committed to building an "AI future medical institution" with a focus on integrating AI and wearable technologies to enhance healthcare delivery across various settings [12][13]. - The company aims to establish a comprehensive health management relationship with patients, providing services that span prevention, diagnosis, treatment, and rehabilitation [13][15]. Industry Context - The article discusses the broader implications of AI in healthcare, highlighting government initiatives aimed at promoting AI applications in medical settings, which align with TreeLan's strategic direction [5][11]. - The establishment of the Open Medical and Healthcare Alliance (OMAHA) aims to enhance data interoperability and support the digital transformation of healthcare [11].

Core Insights - The home appliance industry is currently in a stock competition phase, where companies typically engage in price wars and marketing battles to gain market share. However, Haier Smart Home has demonstrated a different approach, achieving significant revenue and profit growth while reducing sales expenses [1][4]. Group 1: Financial Performance - Haier Smart Home's revenue increased from 227.1 billion yuan in 2021 to 285.9 billion yuan in 2024, a growth of 58.8 billion yuan [1][3]. - The company's profit rose from 13.067 billion yuan in 2021 to 18.741 billion yuan in 2024, an increase of approximately 5.7 billion yuan [1][3]. - Sales expense ratio decreased from 16.1% in 2021 to 11.7% in 2024, a reduction of 4.4 percentage points [3][4]. - Absolute sales expenses fell from 36.5 billion yuan in 2021 to 33.5 billion yuan in 2024, a decrease of 3 billion yuan [3][4]. Group 2: Cost Reduction Strategies - Haier Smart Home achieved cost reduction through comprehensive digital transformation across all processes, including R&D, manufacturing, supply chain, marketing, logistics, and service [4][5]. - The company improved logistics efficiency by increasing direct delivery from company to user, with 74% of orders from county specialty stores being directly delivered to users by the end of September [4][5]. - Global brand and channel expansion has reached a harvest period, leading to reduced costs in overseas sales as the brand matrix is now well-established [4][5]. Group 3: Product Strategy and Innovation - The company focuses on high-end brands and product suites, which enhance pricing power while lowering costs. For instance, the Casarte brand saw an 18% revenue growth in the first three quarters, leading in the high-end appliance market [5][6]. - The sales proportion of Casarte suite products increased to 36%, up 7% year-on-year, while Haier brand suite products rose to 15%, up 11% year-on-year [5][6]. - R&D investment has consistently increased from 8.364 billion yuan in 2021 to 10.74 billion yuan in 2024, indicating a significant annual growth rate [5][6].

【#江中药业改名#】#江中药业改名华润江中# 12月13日，江中药业股份有限公司发布公告称，第十届 董事会第十次会议通过了变更公司名称及证券简称的议案，公司中文名称变更为"华润江中药业股份有 限公司"。 英文名称由"JIANGZHONG PHARMACEUTICAL CO.,LTD" 变更为"China Resources Jiangzhong Pharmaceutical Co.,Ltd"。 2019年2月，华润医药战略重组江中集团。江中药业实控人由江西省国资委变更为中国华润有限公司， 最终实际控制人为国务院国有资产监督管理委员会。 证券简称变更为"华润江中"，证券代码保持不变。 在另一份公告中，江中药业称，本次变更的原因是"有助于强化与华润的品牌协同认知，进一步提升公 司品牌辨识度和市场影响力。" 江中药业股份有限公司现为华润江中制药集团旗下A股上市公司，后者的前身为江中集团。 近年来，"华润系"逐渐入主"江中系"。 2018年5月，江西省政府与华润集团签订战略合作协议，明确由华润医药重组江中集团；同年7月，华润 医药与江中集团签订协议，明确以增资扩股方式成为江中集团持股51%的控股股东。 本公司董事会及 ...

#同仁堂南极磷虾油磷脂含量为0被约谈#【#同仁堂南极磷虾油磷脂含量为0#】#不含磷脂的磷虾油实为 同仁堂贴牌产品#日前，上海市消保委公众号发布文章称，已经约谈疑似造假的南极磷虾油生产商，背 后涉及知名企业、老字号品牌"同仁堂"。 据上海市消保委公众号，一款标称"北京同仁堂99%高纯南极磷虾油"的产品，在网页上写着"高含 量"、"智利进口原料"、"高度提纯"、"1粒≈100只磷虾"，其磷脂标识值为43%，看似是品质出众的优质 产品，但检测结果显示该款产品磷脂含量为0。 专家表示，南极磷虾油产品应该是以南极磷虾为原料提取的虾油，必定含有磷脂成分。针对相关企业涉 嫌造假行为，为了保护消费者合法权益，上海市消保委将于近日约谈该产品的生产企业安徽哈博药业有 限公司和经销商北京同仁堂（四川）健康药业有限公司，要求其对产品的真实情况做出解释。 第一财经记者注意到，北京同仁堂（四川）健康药业有限公司销售的这款南极磷虾油其实可以视作北京 同仁堂的"贴牌"产品，该公司是中国北京同仁堂（集团）有限责任公司的"孙公司"。 此前网上关于"同仁堂"没有双龙标的争议已经发酵。包括北京同仁堂（四川）健康药业有限公司在内的 厂家销售的所谓"同 ...

Group 1 - The core viewpoint of the news is that the new quantity control policy by Kweichow Moutai has led to a significant increase in market prices for its products, with reports of prices rising over 150 yuan per bottle in certain regions [1][2] - Following the announcement of the new policy, the wholesale price of Moutai in Tianjin has surged to 1,630 yuan per bottle, reflecting a two-day increase of over 150 yuan [1] - The retail price in some Beijing smoke shops has returned to 1,680 yuan per bottle, indicating a broader impact on the market due to the price adjustments [1] Group 2 - Kweichow Moutai's short-term measures include halting the distribution of all Moutai products to distributors until January 1, 2026, to alleviate financial pressure on distributors during a tight cash flow period [2] - The long-term structural reform plan involves a significant reduction in the quotas for non-standard products, with specific cuts of 30% for 15-year and 1-liter Flying Moutai, and a 50% reduction for Zodiac Moutai, while completely stopping the supply of colored glaze premium Moutai [2] - Although distributors still have a profit margin with a purchase price of 1,169 yuan per bottle compared to the market price of around 1,600 yuan, the overall cost for distributors remains high due to the inclusion of various products in their quotas [2]